Here are the buy-and-trade parameters for 12 Big Pharma stocks:

Abbott Labs ( ABT) ($35.36) set a multi-year high at $38.77 on May 22. My monthly value level is $22.38 with a weekly risky level at $36.76.

Allergan ( AGN) ($85.43) set a 2013 low at $81.33 on June 24. My weekly pivot is $86.72 with a semiannual risky level at $88.65.

AstraZeneca ( AZN) ($47.99) set a multi-year high at $53.45 on May 28, then fell to $46.87 into June 24. My annual value level is $42.53 with a quarterly risky level at $49.43.

Bristol-Myers Squib ( BMY) ($46.30) set a multi-year high at $49.57 on June 3. My quarterly value level is $43.35 with a weekly risky level at $49.31.

GlaxoSmithKline ( GSK) ($50.10) set a multi-year high at $54.00 on May 28, then a low of $48.30 on June 24. My monthly value level is $47.78 with a weekly pivot at $50.57 and quarterly risky level at $51.33.

Johnson & Johnson ( JNJ) ($86.71) set a multi-year high at $89.99 on May 22, then as low as $82.12 on June 20. My monthly value level is $85.71.

If you liked this article you might like

Fight Off Complacency: Cramer's 'Mad Money' Recap (Fri 9/15/17)

Alibaba, Qorvo, Abbott Laboratories, Square: 'Mad Money' Lightning Round

Walmart Is One of 63 Companies Contributing Massively to Aid Harvey Relief

Abbott Updates Pacemaker, Defibrillator Software to Protect Against Hacking